SAN DIEGO, Jan. 23, 2023 (GLOBE NEWSWIRE) Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that Tina S. Nova, Ph.D. has been elected as
SAN DIEGO, Jan. 23, 2023 (GLOBE NEWSWIRE) Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that Tina S. Nova, Ph.D. has been elected as Executive Chair of the Exagen Board of Directors, effective Jan.
Exagen Inc. (NASDAQ:NASDAQ:XGN) Q3 2022 Earnings Conference Call November 14, 2022 04:30 PM ET Company Participants Ryan Douglas - IR John Aballi - President and CEO Kamal Adawi - CFO Mark.